NEW YORK (GenomeWeb) – Molecular Health is putting the finishing touches on a new product for clinical trials which it plans to launch in the first quarter of 2019.
The solution, called Molecular Health Guide Predictive Engine, uses machine learning methods to predict the potential outcomes and likelihood of success of clinical trials, Rudolf Caspary, the company’s chief information officer, explained in an interview.
Get the full story with
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.